Table 1—

Patient characteristics and dispositions

Patient characteristicsPioglitazone groupGliclazide group
n270297
Sex
    Men171 (63.3)182 (61.3)
    Women99 (36.7)115 (38.7)
Ethnicity
    White253 (93.7)275 (92.6)
    Others17 (6.3)22 (7.4)
Age (years)57 ± 9.856 ± 9.9
Duration of diabetes (years)2.7 ± 3.52.9 ± 3.8
Height (m)1.69 ± 0.091.70 ± 0.09
Weight (kg)91.7 ± 19.989.2 ± 18.2
BMI (kg/m2)32 ± 6.431 ± 5.6
Patient disposition
    Adverse events33 (12.2)25 (8.4)
    Lack of efficacy45 (16.7)86 (29.0)
    Protocol violation6 (2.2)5 (1.7)
    Withdrawal of consent31 (11.5)44 (14.8)
    Lost to follow up2 (0.7)4 (1.3)
    Other6 (2.2)6 (2.0)
    Completed study147 (54.4)127 (42.8)
  • Data are means ± SD or n (%).